Table 3.
Logistic regression analysis to determine melatonin use associated with thrombosis in COVID-19 patients.
| B | SE | Wald | df | Sig. | Exp. (B) | 95% CI for Exp (B) | ||
|---|---|---|---|---|---|---|---|---|
| Lower | Upper | |||||||
| Melatonin | -1.174 | 0.504 | 5.428 | 1 | 0.020* | 0.309 | 0.115 | 0.830 |
| Age | 0.099 | 0.039 | 6.419 | 1 | 0.011* | 1.105 | 1.023 | 1.193 |
| Gender | -0.635 | 0.579 | 1.201 | 1 | 0.273 | 0.530 | 0.170 | 1.650 |
| Hypertension | -0.577 | 0.511 | 1.274 | 1 | 0.259 | 0.561 | 0.206 | 1.530 |
| Ischemic heart disease | 1.335 | 0.564 | 5.599 | 1 | 0.018* | 3.800 | 1.258 | 11.481 |
| Diabetes mellitus | 0.735 | 0.508 | 2.093 | 1 | 0.148 | 2.086 | 0.770 | 5.648 |
| Asthma | 0.649 | 0.688 | 0.891 | 1 | 0.345 | 1.914 | 0.497 | 7.367 |
| Constant | -7.048 | 2.217 | 10.103 | 1 | 0.001* | 0.001 | ||
B, coefficient; SE, standard error of B; df, degree of freedom; Exp. (B), estimated odds ratio; CI, confidence interval for exp (B)
*Significant using binary logistic regression